SPDR® S&P Pharmaceuticals ETF (XPH)

Delayed Data
As of Mar 20
 -0.51 / -1.19%
Today’s Change
Today|||52-Week Range
XPH Regular Dividend: XPH began trading ex-dividend on 03/16/18. A $0.0194 dividend will be paid to shareholders of record as of 03/19/18.

Investment Objective

The investment seeks to provide investment results that- before fees and expenses- correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index")- the fund employs a sampling strategy. It generally invests substantially all- but at least 80%- of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

No recent news for SPDR® S&P Pharmaceuticals ETF.


1 month-1.46% 3 years-10.96%
3 months-2.46% 5 years+9.49%
1 year+1.96% Since inception+11.09%
Data through 03/21/2018

Quote Details

Previous close$42.81
Open day’s range42.13 – 42.91
Net asset value (NAV)42.30 (03/20/2018)
Daily volume58,190
Average volume (3 months)107,269
Data as of 3:59pm ET, 03/20/2018

Peer Comparisonvs. Health ETFs

Performance 5-yr return+9.49%+17.28%
Expense Gross exp ratio0.35%1.30%
Risk 5 year sharpe ratio0.531.02
Net assets$359.8M$3.1B
Average market cap$9.2B$10.4B
Average P/E8.922.9
Dividend / Share--0.34%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
ZTS Zoetis Inc5.12%
BMY Bristol-Myers Squibb4.83%
NKTR Nektar Therapeutics4.82%
MYL Mylan NV4.75%
JAZZ Jazz Pharmaceuticals PLC4.74%
PFE Pfizer4.62%
MRK Merck4.44%
PRGO Perrigo Company PLC4.33%
JNJ Johnson & Johnson4.20%
AGN Allergan4.18%